Sampleminded VP Departs for Humanitarian Visit to South Africa

Part of Global Caring Initiative for Healthcare Information Technology & Data Solutions Company SALT LAKE CITY—March 6, 2017— Sampleminded VP of Business Development Christina Goleman will travel on a 13-day humanitarian visit to South Africa. The effort is in partnership with South Africa Cares for Life, a South African-based nonprofit focused on “changing the destiny… Read more »

Q&A – Finding the Right LIMS & Clinical Trials Operations Solutions

We sat down with the thought leaders of Sampleminded and asked them a series of questions regarding finding the right LIMS and clinical trials operations solutions. Here’s what they had to say. Q:  What differentiates one LIMS and clinical trials solutions provider from another? Most organizations focus on key areas like features, functionality, integration capabilities,… Read more »


In December 2016, Former President Obama signed the 21st Century Cures Act. Two years in the making, this landmark, bipartisan bill seeks to drive advancement of the American healthcare system. Costing $6.3 billion dollars, the Cures Act will: Accelerate the approval of new drugs and medical devices Reinvest in Vice President Biden’s Cancer Moonshot, aimed at… Read more »

Sampleminded Poised to Aid Clinical Trial Sponsors with Compliance of New Data Sharing Rules

The clinical trial rules are changing, and the question is, how will researchers, laboratories and drug companies meet the requirements? Beginning January 18, 2017, researchers will need to meet tighter parameters regarding the reporting of clinical trials data according to new policies and regulations released by the National Institutes of Health and U.S. Health and… Read more »

Sampleminded Announces Betsy Kleba, PhD Scientific Officer

Associate Professor & Leading Microbiology Researcher Joins Company’s Product Team SALT LAKE CITY—November 29, 2016—Sampleminded announces that Betsy Kleba, PhD, has joined the Salt Lake City-based company as its Scientific Officer. The former associate professor from Westminster College will lend her expertise in microbial pathogenesis, immunology, and research to the Product team. As a partner… Read more »

Sampleminded Announces Christina Goleman as VP of Business Development

Seasoned Business Leader & Molecular Diagnostics Expert to Expand Company’s LIS & CLINOPS Reach SALT LAKE CITY—November 8, 2016—Sampleminded is pleased to name Christina Goleman as Vice President of business development. Goleman brings her years of business leadership experience in healthcare, laboratory science, and analytics to the Salt Lake City-based company. Sampleminded, a proven leader… Read more »

Sampleminded Announces the Release of Enhanced Laboratory Information and Specimen Tracking System

Innovation that answers the growing needs of laboratory industry. Salt Lake City— Sampleminded— Today at the Association of Molecular Pathology Annual Conference (AMP), Sampleminded announced the immediate availability of their enhanced Laboratory Information and Specimen Tracking solutions. A suite of customizable, configurable tools and products developed to address the rapidly changing needs of research and… Read more »

Introducing Professor Steenblik

Many of Sampleminded’s employees have various interesting hobbies and side gigs, and now we can add College Professor to the list. Daniel Steenblik, Founder and VP of Engineering, will be teaching  CMPT 322 Software Engineering  as an adjunct professor at Westminster College in Salt Lake City for the Spring 2016 Semester. The team-oriented Software Engineering course… Read more »

Software as a Circus: Clown Computing with Dan

Our software engineering team took a {brief} break from the daily grind last Friday to pop in to Professor Greg Gagne’s Software Engineering class at Westminster College.  We always look forward to the opportunity to to see what these students are up to, and to promote our internship program. After listening to the students’ project presentations, Dan Steenblik… Read more »

Sampleminded Laboratory System Allows Cologuard to Significantly Increase Test Volume

Sampleminded is pleased to announce today our ongoing collaboration with Exact Sciences, creator of Cologuard®, the first FDA-approved noninvasive stool DNA screening test for colorectal cancer. By utilizing Sampleminded’s highly configurable and intuitive Laboratory System, Exact Sciences has been able to successfully manage the increasing number of samples and test results due to Cologuard’s global expansion. “We evaluated… Read more »